-
O'Mathuna DP. DHEA for women with systemic lupus erythematosus. Altern Med Alert 2003;6(10):112-115.
-
Lynch DM. Rye grass pollen for benign prostatic hyperplasia, protatitis, and prostatodynia. Altern Med Alert 2003;6(10):109-112.
-
Triggering ventricular premature beats from distal Purkinje fibers or the right ventricular outflow tract are critical initiating factors in patients with VF associated with the long QT and Brugada syndromes. Elimination of these focal triggers can provide relief from recurrent arrhythmias.
-
Gaster et al from Odense University Hospital and the University of Southern Denmark report the results of a randomized, prospective study comparing 5-year major adverse clinical events and cost outcomes after PCI with or without IVUS guidance.
-
Losartan therapy of hypertensive patients with LVH resulted in greater LVH regression as compared to atenolol independent of blood pressure control and baseline ECG findings.
-
-
A Strategy to Reduce Cardiovascular Disease by More Than 80 Percent;
Pearly Penile Papules: Still No Reason for Uneasiness; The Epidemiology
of Major Depressive Disorder; Urinary Tetrahydroaldosterone as a Screen
for Aldosteronism; Finasteride and Prostate Cancer; Impermeable Bed
Covers in Patients with Allergic Rhinitis
-
The frequency with which patients are hospitalized for atrial fibrillation is increasing dramatically with a large proportion of the increase due to an increased number of elderly patients in the population. Part of this increase may also be due to changes in management strategies for atrial fibrillation. Inpatient observation for initiation of antiarrhythmic therapy or for anticoagulation is now commonly recommended, particularly in elderly patients.
-
In hypertensive patients without clinically evident vascular disease, losartan was more effective than atenolol in preventing future vascular events independent of blood pressure control.
-
The DANAMI-2 investigators, representing 29 hospitals and a patient base reflecting 62% of the Danish population, have reported on a trial assessing whether randomization to either fibrinolytic therapy or transport to an interventional facility results in differing major cardiovascular rates following acute ST elevation myocardial infarction (STEMI).